Artivion Inc. has announced a management change with the appointment of Lance A. Berry as Chief Operating Officer, effective August 11, 2025. Berry, who currently serves as Executive Vice President, Chief Financial Officer, and Treasurer, will retain these roles in addition to his new position. The company also announced the retirement of Marshall S. Stanton, Senior Vice President, Clinical Research and Chief Medical Officer. Dr. Stanton is expected to continue providing strategic advice and transition services for up to a year following his retirement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.